The Journal of Pain
Volume 10, Issue 8 , Pages 818-828 , August 2009

Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial

  • Aziz Shaibani

      Affiliations

    • Nerve and Muscle Center of Texas, Houston, Texas
    • Corresponding Author InformationAddress reprint requests to Dr. Aziz Shaibani, Nerve and Muscle Center of Texas, 6624 Fannin, Suite 1670, Houston, TX 77030.
    • ,
  • Salah Fares

      Affiliations

    • Nerve and Muscle Center of Texas, Houston, Texas
    • Wayne State University, Sinai Grace Hospital, Detroit, Michigan
    • ,
  • Jean-Louis Selam

      Affiliations

    • University Clinical Investigators, Inc., Diabetes Research Center, Tustin, California
    • ,
  • Armen Arslanian

      Affiliations

    • Beacon Clinical Research, Brockton, Massachusetts
    • ,
  • Jeffrey Simpson

      Affiliations

    • SCHWARZ BIOSCIENCES, Inc., a Member of the UCB Group, Research Triangle Park, North Carolina
    • ,
  • David Sen

      Affiliations

    • SCHWARZ BIOSCIENCES, Inc., a Member of the UCB Group, Research Triangle Park, North Carolina
    • ,
  • Sabine Bongardt

      Affiliations

    • Schwarz Pharma, AG, UCB Group, Monheim, Germany

Received 10 March 2008 ,Revised 22 December 2008 ,Accepted 26 January 2009.

References 

  1. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA. 1998;280:1831–1836
  2. Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur J Pharmacol. 2006;539:64–70
  3. Beyreuther BK, Freitag J, Heers C, Krebsfanger N, Scharfenecker U, Stohr T. Lacosamide: A review of preclinical properties. CNS Drug Rev. 2007;13:21–42
  4. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: A summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res. 2007;73:1–52
  5. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care. 2005;28:956–962
  6. Bretin S, Rogemond V, Marin P, Maus M, Torrens Y, Honnorat J, et al. Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J Neurochem. 2006;98:1252–1265
  7. Cruccu G. Treatment of painful neuropathy. Curr Opin Neurol. 2007;20:531–535
  8. Doty P, Rudd GD, Stoehr T, Thomas D. Lacosamide. Neurother. 2007;4:145–148
  9. Errington AC, Stohr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008;73:157–169
  10. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: A validation study. J Pain Symptom Manage. 2003;25:406–411
  11. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–158
  12. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115:254–263
  13. Hovinga CA. SPM-927 (Schwarz Pharma). IDrugs. 2003;6:479–485
  14. Jensen TS, Backonja MM, Jimenez SH, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res. 2006;3:108–119
  15. Lamictal [package insert]. 2007. GlaxoSmithKline
  16. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology. 2004;63:2104–2110
  17. Lyrica [package insert]. 2007. Pfizer Pharmaceuticals LLC
  18. McQuay HJ, Derry S, Moore RA, Poulain P, Legout V. Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain. Pain. 2008;135:217–220
  19. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al. Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12:13–21
  20. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, et al. Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects. Neurology. 2004;63:865–873
  21. Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: A phase 2 double-blind placebo-controlled study. Clin J Pain. 2007;23:150–158
  22. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350–354
  23. Shaibani A, Biton V, Rauck R, Koch B, Simpson J. Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial. Eur J Pain. 2008;
  24. Stohr T, Beyreuther B, and Freitag J: Lacosamide modulates collapsin response mediator protein 2 (CRMP-2). American Epilepsy Society Annual Meeting. 2006
  25. Stohr T, Krause E, Selve N. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain. Eur J Pain. 2006;10:241–249
  26. Wong M, Chung JWY, Wong TKS. Effects of treatments for symptoms of painful diabetic neuropathy: Systematic review. BMJ. 2007;335:87
  27. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain. 2006;22:681–685
  28. Ziegler D. Treatment of diabetic polyneuropathy: Update 2006. Ann N Y Acad Sci. 2006;1084:250–266

 Supported in part by SCHWARZ BIOSCIENCES, GmbH, UCB Group, Monheim, Germany, which provided the trial supplies, and SCHWARZ BIOSCIENCES, Inc., UCB Group, Research Triangle Park, North Carolina, which sponsored and funded the trial.

PII: S1526-5900(09)00310-1

doi: 10.1016/j.jpain.2009.01.322

The Journal of Pain
Volume 10, Issue 8 , Pages 818-828 , August 2009

Article Tools

* Image Usage & Resolution